The battle between host and SARS-CoV-2: Innate immunity and viral evasion strategies
Authors:
Open Access
- 14 February 2022
- journal article
- review article
- Published by Elsevier in Molecular Therapy
- Vol. 30 (5) , 1869-1884
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
This publication has 167 references indexed in Scilit:
- Overview of Complement Activation and RegulationSeminars in Nephrology, 2013
- A Common Strategy for Host RNA Degradation by Divergent VirusesJournal of Virology, 2012
- Discovery of Seven Novel Mammalian and Avian Coronaviruses in the Genus Deltacoronavirus Supports Bat Coronaviruses as the Gene Source of Alphacoronavirus and Betacoronavirus and Avian Coronaviruses as the Gene Source of Gammacoronavirus and DeltacoronavirusJournal of Virology, 2012
- Systematic identification of type I and type II interferon-induced antiviral factorsProceedings of the National Academy of Sciences, 2012
- Interferon-stimulated genes and their antiviral effector functionsCurrent Opinion in Virology, 2011
- Immune Signaling by RIG-I-like ReceptorsImmunity, 2011
- A diverse range of gene products are effectors of the type I interferon antiviral responseNature, 2011
- Crystal structure of RIG-I C-terminal domain bound to blunt-ended double-strand RNA without 5′ triphosphateNucleic Acids Research, 2010
- Coronaviruses post-SARS: update on replication and pathogenesisNature Reviews Microbiology, 2009
- The roles of TLRs, RLRs and NLRs in pathogen recognitionInternational Immunology, 2009